Introduction of a manual vacuum aspiration service: a model of service within a NHS Sexual Health Service

We assessed the applicability, acceptability and cost implications of introducing the manual vacuum aspiration (MVA) technique with local anaesthesia for fully conscious first-trimester termination of pregnancy within our service and for our population. The outpatient setting of a Pregnancy Advisory...

Full description

Saved in:

Bibliographic Details
Published in:	The journal of family planning and reproductive health care Vol. 41; no. 1; p. 27
Main Authors:	Pillai, Mary, Welsh, Val, Sedgeman, Kirsty, Gazet, A Caroline, Staddon, Juliet, Carter, Helen
Format:	Journal Article
Language:	English
Published:	England 01-01-2015
Subjects:	Abortifacient Agents, Nonsteroidal - therapeutic use Abortion, Induced - methods Cost-Benefit Analysis Diclofenac - therapeutic use Female Humans Intrauterine Devices - utilization Misoprostol - therapeutic use Outpatients Patient Satisfaction Pregnancy Reproductive Health Safety Self Administration State Medicine Vacuum Curettage - methods Health Economics Abortion Service Delivery
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We assessed the applicability, acceptability and cost implications of introducing the manual vacuum aspiration (MVA) technique with local anaesthesia for fully conscious first-trimester termination of pregnancy within our service and for our population. The outpatient setting of a Pregnancy Advisory Service within a NHS Sexual Health Service. Self-administered misoprostol and diclofenac, extra-amniotic local anaesthetic gel and paracervical mepivicaine prior to MVA. Routinely collected data were used to provide information on uptake, demographic details, timing, pain score, complications, contraceptive uptake, and economic implications for our service. MVA was chosen by 305/1681 potentially eligible women. Forty percent had the procedure on the day they attended for assessment. Seventy-nine percent gave a pain score of 3 or less out of 10. Complications occurred in six cases (2%); these included cervical rigidity, a false passage, retained products of conception, bleeding (more than 200 ml) and one allergic reaction. Eighty percent of women chose to commence a long-acting reversible contraception (LARC) method at the time of MVA. Operating theatre utilisation was reduced by one termination list per week and cost savings of around £60,000 per annum were realised. The technique for fully conscious MVA was very suitable for our outpatient setting. It was associated with very low levels of pain and bleeding. The uptake of LARC was high, and particularly the ability to provide intrauterine contraception at MVA was associated with a very high uptake.
ISSN:	2045-2098
DOI:	10.1136/jfprhc-2013-100700